Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • SAVIC and SupplyChainz Infotech LLP Merge to Create a New Era of Systems Integration Solutions         Business
  • TalantonCore, Led by Nikhil Jain, leaps to harness the hidden talent of Indian Artists Entertainment
  • Vivekananda Kondapalli Expands Film Slate With U.S., European and Indian Collaborations Lifestyle
  • Indian Achievers’ Forum in association with CSR Times hosts annual conclave in Goa, CM Sawant calls for greater participation World
  • Urban Indian households likely to spend nearly INR 20,000 on average this festive season; 6% lower than 2025 Business
  • Clastek Engineering Limited Filed DRHP With NSE Emerge Business
  • Shaarib–Toshi Unveil “Ishq Da Haasil” at Grand Launch of Their Dream Sufi Album Roohaniyat Entertainment
  • Hafele Zenith Digital Lock Brings Intelligent Control with Advanced Smart Technologies Business

Alcon Announces Launch of AcrySof IQ Vivity in India

Posted on January 7, 2022 By

Alcon Announces Launch of AcrySof IQ Vivity in India, the First and Only Presbyopia-Correcting Lens Implant with Proprietary Wavefront-Shaping Technology for Cataract Surgery

New Delhi (India), January 7: Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology – the AcrySof® IQ Vivity® IOL (Vivity®). This new PC-IOL is now available to Indian ophthalmologists for their patients undergoing cataract surgery. Cataracts usually impact older adults and are often linked to presbyopia, which reduces the ability to view near objects and is the most common refractive disorder in patients undergoing cataract surgery.

Vivity is the first and only extended depth of focus lens with Alcon’s proprietary X-WAVE™ technology, which stretches and shifts light without splitting it. Vivity delivers a continuous range of vision at various distances like monofocal-quality distance (far) with excellent intermediate (at arm’s length, e.g., reading the newspaper, working on a laptop) and functional near (up close, e.g., reading books, mobile phone), with a clinically proven exceptionally low rate of visual disturbances. Commemorating World Sight Day on October 14, Vivity aims to meet the needs of cataract patients interested in enhanced visual performance, reduced spectacle dependence while enabling more independence.

Vivity expands Alcon’s growing portfolio of PC-IOLs and is built on Alcon’s trusted and proven AcrySof IQ IOL platform with implants exceeding 125 million eyes globally. According to results from two large independent clinical trials, patients who had the Vivity lens implanted experienced renewed vision and lifestyle benefits. Vivity patients reported 20/20 vision at a distance, more than 20/25 at intermediate and 20/32 for near vision. Additionally, 94% and 92% of Vivity patients reported superior vision at distance and arm’s length, respectively, without glasses in bright light.

Cataracts are the most common cause of vision loss globally and the primary cause of preventable blindness in India. Cataract surgery involves removing the clouded natural crystalline lens followed by a replacement with an intraocular lens (IOL). The prevalence of cataracts in India is 9.9 million; each year, 6.5 million surgeries are performed by around 12,200 cataract surgeons.

Among the 6.5 million undergoing cataract surgery in India, 90% of patients continue to depend on glasses for most of their daily activities even after surgery. An independent survey revealed that 95% of these patients expressed the willingness to get rid of glasses after the surgery. Sadly, despite the desire, there are several barriers. One of the significant barriers is the limitation of the current technology to address the visual needs of all patient groups.

“Traditional IOLs typically address distance vision. The new generation of seniors spend significant time with technology screens like phones, tablets and computers, and currently experience a massive gap in near and intermediate vision post-surgery,” said Shalav Modi, Country Franchise Head, Surgical, and Country Manager at Alcon Laboratories India Pvt Ltd. “Vivity addresses this gap and the desire of patients who want to get rid of cataracts and presbyopia at the same time. As a result, patients can be less dependent on glasses for most activities post-surgery, enhancing their visual satisfaction and quality of life,” Modi added.

Vivity is the first and only non-diffractive* presbyopia-correcting IOL with minimum visual disturbance profile. Unlike conventional presbyopia-correcting IOLs, which split light, Vivity utilizes almost all light energy, providing good vision quality in all lighting conditions. Vivity is approved by the Central Drug Standard Control Organization (CDSCO).

Leading ophthalmic surgeons worldwide who have had a chance to implant Vivity have said that they can now offer presbyopia correction to a more significant number of patients undergoing cataract surgery, with strong satisfaction rates. Based on a recent survey, 93% of patients said they would definitely recommend the new AcrySof Vivity to their friends and relatives.

Health Tags:Healthcare

Post navigation

Previous Post: Practically Launches an Exciting ‘School and Student Championship Quiz’
Next Post: Sacred Weaves At Office Inauguration Ceremony of Meta in Gurgaon

Related Posts

  • Child Help Foundation Conducted Menstrual Health Programme Across India Health
  • Healing Hospital Chandigarh Achieves Life-Changing Spinal Correction Surgery for 30-Year-Old Patient Health
  • The Good Sage Launches India’s First AI-Based Vitamin D3 Assessment Tool – Free, 2-Minute Test Requires No Blood Sample Business News
  • Rare disease Blood-Sweating Disorder Successfully Treated with Advanced Homeopathy – Dr AK dwivedi Health
  • Female Age and Reproduction By Dr Ruchi Thakor – Ruchi Candor Women Hospital & IVF Center. Health
  • The Ultimate Guide to Choosing The Best bariatric surgeon in Punjab Health

Recent Posts

  • Fredna Dental Systems Partners with South Korea’s & Introduces BIOTEM AR Implant Technology in India
  • Make Your Financial Plans Easier with a Personal Loan
  • Gohil Group plans G-Farm retail outlets in Ahmedabad and Surat
  • P.C. Chandra Group’s 13th Edition of Jahar Lal Chandra Merit Scholarship Programme
  • Quest Alliance CEO Aakash Sethi Named to TIME100 Next: India, TIME’s Inaugural List of 100 Individuals Defining the Future of India

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Toyam Sports Limited buys out Hyderabad franchise in Legends League Cricket Press Release
  • The Future of Money: Will Cryptocurrency Replace Fiat Currency? Business
  • GenWorks Collaboration With Andhra Pradesh Government Empowers Women’s Wellness Business
  • Kaustubh Sonalkar releases his second book ‘In the Shadows’ in the fiction genre Lifestyle
  • AB de Villiers & Wolf7Pay – The Collaboration of Masters Sports
  • Breast-Milk Donation Awareness Summit held on World Human Milk Donation Day by NeoLacta Lifesciences Business
  • Zandu Care Launches New Advanced Shilajit Variant with 24k Gold & 9 Potent Herbs Business
  • HECS Organizes Technical Seminar on MBR-based STP & ETP for Hospitals Jointly with PWD (Medical Division) & CMC Vellore Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme